Skip to content

Pain After Insufflation for Robotic Sacrocolpopexy (PAIRS) Trial

Pain After Insufflation for Robotic Sacrocolpopexy (PAIRS) Trial

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04858438
Enrollment
0
Registered
2021-04-26
Start date
2021-04-02
Completion date
2025-02-01
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Keywords

Sacrocolpopexy, Pneumoperitoneum, Postoperative pain

Brief summary

This study evaluates post-operative pain between different insufflation pressures during robotic-assisted sacrocolpopexy. Subjective pain and narcotic usage after surgery will be measured.

Detailed description

This is a prospective single-blind randomized controlled trial of adult women undergoing robotic-assisted sacrocolpopexy for pelvic organ prolapse. Each surgery will be performed by a board-certified Female Pelvic Medicine & Reconstructive Surgery (FPMRS) surgeon with a standard technique other than pneumoperitoneum level. A sacrocolpopexy for apical prolapse may be performed at the same time as a hysterectomy and other clinically indicated procedures if desired by the patient and as part of the standard of care. Patients will be stratified by hysterectomy prior to randomization. Postoperatively, patients will be evaluated with a Visual Analogue Scale (VAS) as well as prescribed narcotic analgesic use and followed up to 2 weeks.

Interventions

PROCEDUREInsufflation during surgery

This is the amount of insufflation using during the surgical procedure.

Sponsors

Henry Ford Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Patients will be unaware of their study group status and unaware of level of pneumoperitoneum used during their surgical procedure.

Intervention model description

Patients will be randomized to receive either standard pneumoperitoneum (15 mmHg) versus a lower level of pneumoperitoneum (12 mmHg).

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled to have a robotic-assisted sacrocolpopexy surgery for pelvic organ prolapse. * Age 18-90 years * Can read and understand the consent form and consents to the procedure

Exclusion criteria

* Patients undergoing other procedures * Patients who do not consent to participate.

Design outcomes

Primary

MeasureTime frameDescription
Post-operative Pain on a visual analogue scale, ranging from 1-10 with a higher score meaning more pain.Pain will be assessed within 24 hours of the surgery. .Pain will be assessed during the 24-hour post-operative period.
Safety using Operation length, blood loss, need to increase insufflation, operative conversion rates. These are all counts with higher numbers meaning worse outcomes.Safety will be assessed during the procedure.The safety of the lower insufflation pressure will be assessed during the procedure.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026